Human Genome Epidemiology Literature Finder
|
Records 1 - 19 (of 19 Records) |
| Query Trace: Recurrence and ERCC1[original query] |
|---|
| Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer. Experimental & molecular medicine 2006 Jun 38 (3): 320-4. Kang Sokbom, Ju Woong, Kim Jae Weon, Park Noh Hyun, Song Yong Sang, Kim Seung Cheol, Park Sang Yoon, Kang Soon Beom, Lee Hyo P |
| Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer. Cancer biology & therapy 2010 Jul 10 (1): 13-8. Gao Rui, Price Douglas K, Dahut William L, Reed Eddie, Figg William |
| Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. International journal of molecular epidemiology and genetics 2011 2 (2): 185-95. Peethambaram Prema, Fridley Brooke L, Vierkant Robert A, Larson Melissa C, Kalli Kimberly R, Elliott Elaine A, Oberg Ann L, White Kristin L, Rider David N, Keeney Gary L, Cunningham Julie M, Hartmann Lynn C, Goode Ellen |
| [Predictive values of platinum-related gene polymorphisms in gastric cancer patients on oxaliplatin-based adjuvant chemotherapy]. Zhonghua yi xue za zhi 2011 Jan 91 (4): 256-9. Liu Yong-ping, Ling Yang, Zhang Ya-ping, Liu Bao-r |
| Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum. Gynecologic oncology 2012 Sep 126 (3): 448-54. Deloia Julie A, Bhagwat Nikhil R, Darcy Kathleen M, Strange Mary, Tian Chunquio, Nuttall Kevin, Krivak Thomas C, Niedernhofer Laura |
| Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 May 22 (5): 987-92. White Kristin L, Vierkant Robert A, Fogarty Zachary C, Charbonneau Bridget, Block Matthew S, Pharoah Paul D P, Chenevix-Trench Georgia, , Rossing Mary Anne, Cramer Daniel W, Pearce Celeste Leigh, Schildkraut Joellen M, Menon Usha, Kjaer Susanne Kruger, Levine Douglas A, Gronwald Jacek, Culver Hoda Anton, Whittemore Alice S, Karlan Beth Y, Lambrechts Diether, Wentzensen Nicolas, Kupryjanczyk Jolanta, Chang-Claude Jenny, Bandera Elisa V, Hogdall Estrid, Heitz Florian, Kaye Stanley B, Fasching Peter A, Campbell Ian, Goodman Marc T, Pejovic Tanja, Bean Yukie, Lurie Galina, Eccles Diana, Hein Alexander, Beckmann Matthias W, Ekici Arif B, Paul James, Brown Robert, Flanagan James M, Harter Philipp, du Bois Andreas, Schwaab Ira, Hogdall Claus K, Lundvall Lene, Olson Sara H, Orlow Irene, Paddock Lisa E, Rudolph Anja, Eilber Ursula, Dansonka-Mieszkowska Agnieszka, Rzepecka Iwona K, Ziolkowska-Seta Izabela, Brinton Louise, Yang Hannah, Garcia-Closas Montserrat, Despierre Evelyn, Lambrechts Sandrina, Vergote Ignace, Walsh Christine, Lester Jenny, Sieh Weiva, McGuire Valerie, Rothstein Joseph H, Ziogas Argyrios, Lubinski Jan, Cybulski Cezary, Menkiszak Janusz, Jensen Allan, Gayther Simon A, Ramus Susan J, Gentry-Maharaj Aleksandra, Berchuck Andrew, Wu Anna H, Pike Malcolm C, Van Denberg David, Terry Kathryn L, Vitonis Allison F, Doherty Jennifer A, Johnatty Sharon E, Defazio Anna, Song Honglin, Tyrer Jonathan, Sellers Thomas A, Phelan Catherine M, Kalli Kimberly R, Cunningham Julie M, Fridley Brooke L, Goode Ellen |
| Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome. International journal of molecular sciences 2013 14 (2): 4121-34. Huang Ming-Yii, Wang Jaw-Yuan, Huang Meng-Lin, Chang Hui-Jen, Lin Shiu- |
| An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort. BMC cancer 2013 13 (1): 489. Smith David Hersi, Christensen Ib Jarle, Jensen Niels Frank, Markussen Bo, Müller Sven, Nielsen Hans Jørgen, Brünner Nils, Nielsen Kirsten Va |
| Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx. International journal of cancer. Journal international du cancer 2013 Aug 133 (3): 695-704. Song Xicheng, Sturgis Erich M, Jin Lei, Wang Zhongqiu, Wei Qingyi, Li Guoj |
| A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44. Findlay J M, Middleton M R, Tomlinson |
| Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients. Carcinogenesis 2014 Sep 35 (9): 2031-8. Li Yangkai, Liu Zhensheng, Liu Hongliang, Wang Li-E, Onodera Hisashi, Suzuki Akihiro, Suzuki Koyu, Wadhwa Roopma, Elimova Elena, Sudo Kazuki, Shiozaki Hironari, Estrella Jeannelyn, Lee Ju-Seog, Song Shumei, Tan Dongfeng, Ajani Jaffer A, Wei Qing |
| [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy]. Zhonghua fu chan ke za zhi 2013 Nov 48 (11): 847-52. Qi Bing-li, Li Yan, Wang Na, Zhou Rong-miao, Hu Pei, Kang Sh |
| Association between XRCC1 and ERCC1 single-nucleotide polymorphisms and the efficacy of concurrent radiochemotherapy in patients with esophageal squamous cell carcinoma. Oncology letters 2017 Feb 13 (2): 704-714. Huang Xue, Liu Changmin, Cui Yayun, Zhang Heping, Liu Yongping, Zhou Xifa, Luo Judo |
| Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk. PloS one 2018 13 (8): e0202112. Tsai Chia-Wen, Chang Wen-Shin, Shen Te-Chun, Su Chen-Hsien, Wang Hwei-Chung, Liu Liang-Chih, Bau Da-Ti |
| Polymorphisms in ERCC5 rs17655 and ERCC1 rs735482 Genes Associated with the Survival of Male Patients with Postoperative Oral Squamous Cell Carcinoma Treated with Adjuvant Concurrent Chemoradiotherapy. Journal of clinical medicine 2019 1 8 (1): . Senghore Thomas, Chien Huei-Tzu, Wang Wen-Chang, Chen You-Xin, Young Chi-Kuang, Huang Shiang-Fu, Yeh Chih-Chi |
| Expression of astrocyte-elevated gene-1 indicates prognostic value of fluoropyrimidine-based adjuvant chemotherapy in resectable stage III colorectal cancer. Pathology international 2021 9 71 (11): 752-764. Lin Long-Wei, Lai Peng-Sheng, Chen Ying-Yin, Chen Chung- |
| The association between the ERCC1/2 polymorphisms and radiotherapy efficacy in 87 patients with non-small cell lung cancer. Journal of thoracic disease 2021 6 13 (5): 3126-3136. Jiang Chenxue, Guo Yanling, Li Yefei, Kang Jingjing, Sun Xiaojiang, Wu Hongyu, Feng Jianguo, Xu Yapi |
| ERCC1 and MGMT Methylation as a Predictive Marker of Relapse and FOLFOX Response in Colorectal Cancer Patients from South Tunisia. Genes 2023 7 14 (7): . Dhouha Jamai, Raja Gargouri, Boulbaba Selmi, Abdelmajid Khab |
| Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients. Frontiers in immunology 2023 6 14 1188030. Oliver Hoffmann, Sebastian Wormland, Ann-Kathrin Bittner, Julian Hölzenbein, Esther Schwich, Sabine Schramm, Hana Rohn, Peter A Horn, Rainer Kimmig, Sabine Kasimir-Bauer, Vera Rebma |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: